Resultados de la búsqueda 161-170 of 2865 for Inhibition

  1. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    Breast Cancer Discussions. shebell · Aromatase Inhibitors: How to choose and manage side effects? 88 Replies Mon, Apr 06, 2026.

  2. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    Breast Cancer Discussions. shebell · Aromatase Inhibitors: How to choose and manage side effects? 88 Replies Mon, Apr 06, 2026.

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Probiotics Preventing Immune Checkpoint Inhibitor-Induced Colitis ... To evaluate the incidence of immune checkpoint inhibitors (ICI)-induced colitis (IIC) ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring salvage therapy as assessed ...

  5. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    Breast Cancer Discussions. shebell · Aromatase Inhibitors: How to choose and manage side effects? 88 Replies Mon, Apr 06, 2026.

  6. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    Breast Cancer Discussions. shebell · Aromatase Inhibitors: How to choose and manage side effects? 88 Replies Mon, Apr 06, 2026.

  7. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    Aromatase Inhibitors: How to choose and manage side effects? 88 Replies Mon, Apr 06, 2026. roxy66 · Triple negative - newly diagnosed and looking for your ...

  8. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    Aromatase Inhibitors: How to choose and manage side effects? 88 Replies Mon, Apr 06, 2026. roxy66 · Triple negative - newly diagnosed and looking for your ...

  9. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    Breast Cancer Discussions. shebell · Aromatase Inhibitors: How to choose and manage side effects? 88 Replies Mon, Apr 06, 2026.

  10. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    ... inhibitors treatments, have been unsuccessful or not well tolerated, and the patient has a GFR ≥ 45 ml/min/1.73m2, or the patient is post renal transplantation ...